Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18
Authors:
- 31 January 2003
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 52 (2) , 107-115
Abstract
Tumor cells stimulate natural killer (NK) cell effector functions, but the regulation of cytokine secretion and cytolysis is incompletely understood. We tested whether oral and pharyngeal squamous cell carcinoma cell lines differentially stimulated NK cell interferon-γ (IFN-γ) secretion and cytolysis using a clone of the NK-92-transformed human NK cell line, NK92.35. SCC-4 and SCC-25 cells, but not FaDu or Cal 27 cells, stimulated robust NK92.35 IFN-γ secretion. All four carcinoma cell lines were lysed by NK92.35 cells. These findings indicate that carcinoma cells differentially stimulate NK cell IFN-γ secretion and cytolysis. In Transwell experiments, a combination of SCC-4 or SCC-25 cell soluble factors and contact with FaDu cells synergistically stimulated NK92.35 cell IFN-γ secretion. Stimulatory SCC-4 cells constitutively secreted IL-18, a cytokine that potently augments IFN-γ secretion by T cells and NK cells. In contrast, poorly stimulatory FaDu cells produced little or no IL-18, but synergized with recombinant IL-18 to stimulate NK92.35 IFN-γ secretion. mAb to IL-18 or IL-18 receptor diminished SCC-4-stimulated IFN-γ secretion by NK92.35 cells and by nontransformed NK cells. Thus, IL-18 was necessary for optimal carcinoma stimulation of NK cell IFN-γ secretion. In vivo, oral and upper aerodigestive tract epithelia and carcinomas produced IL-18, but one squamous cell carcinoma had heterogeneous IL-18 expression. Thus IL-18 production can account for squamous cell carcinoma differential stimulation of NK cell effector functions in vitro and may be important for stimulation of NK cells in vivo.Keywords
This publication has 36 references indexed in Scilit:
- A subset of natural killer cells is greatly expanded within inflamed jointsArthritis & Rheumatism, 2002
- The biology of human natural killer-cell subsetsTrends in Immunology, 2001
- Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cellsNature Immunology, 2000
- IL-18 Activates STAT3 in the Natural Killer Cell Line 92, Augments Cytotoxic Activity, and Mediates IFN-γ Production by the Stress Kinase p38 and by the Extracellular Regulated Kinases p44 erk-1 and p42 erk-2 1The Journal of Immunology, 2000
- In vivonatural killer cell activities revealed by natural killer cell-deficient miceProceedings of the National Academy of Sciences, 2000
- The role of IL-18 in innate immunityCurrent Opinion in Immunology, 2000
- Counterregulation of Interleukin-18 mRNA and Protein Expression During Cutaneous Wound Repair in MiceJournal of Investigative Dermatology, 1999
- Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude miceInternational Journal of Cancer, 1999
- Interferon-γ: Biology and Role in Pathogenesis1996
- A patient with simultaneous absence of “classical” natural killer cells (CD3−, CD16+, and NKH1+) and expansion of CD3+, CD4−, CD8−, NKH1+ subsetJournal of Allergy and Clinical Immunology, 1990